Cost-Effective Analysis

Undiagnosed and Undertreated Sleep Apnea Costs U.S. Employers More Than $180 Billion Annually

George Padron
Cost-Effective Analysis, Real World Evidence, HEOR & Economic Modeling, Respiratory & Pulmonary Care | Mar 14, 2026
A study estimates OSA syndrome costs U.S. employers over $180 billion yearly in productivity losses, making the case for broader screening and CPAP coverage.

Antidepressant Discontinuation in Pregnancy Leads to Increased ED Costs and Utilization

Sonia Reyes
Cost-Effective Analysis, Public Health Initiatives, Practice Management, Care Coordination | Feb 13, 2026
SMFM research links SSRI/SNRI discontinuation in pregnancy to nearly double the psychiatric ED utilization, with downstream costs in preterm birth and postpartum care that health plans should monitor.

Health Care Spending Reaches 18% of US GNP

George Padron
Cost-Effective Analysis, Healthcare Headlines, Patient-Reported Outcomes | Jan 24, 2026
ational healthcare spending reached $5.3 trillion in 2024, with utilization and service intensity driving growth rather than price increases, CMS reports.

AI Emerges as Central Theme at Healthcare Investment Conference

George Padron
AI & Critical Decision Support, Digital Therapeutics, Cost-Effective Analysis, Appeals & Denials Management | Jan 17, 2026
The J.P. Morgan Healthcare Conference highlighted AI transformation in prior authorization and care coordination, though provider-payer tensions remain evident.

Rapid Weight Regain After Medication Cessation Tests Cost-Effectiveness Models

George Padron
Cost-Effective Analysis, Diabetes & Metabolic Diseases | Jan 12, 2026
A BMJ review finds that weight returns to baseline within 1.7 years after stopping medication, faster than economic models predict, which impacts formulary decisions.